This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
CBRE (CBRE) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
CBRE (CBRE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's How Much a $1000 Investment in CBRE Group Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
CBRE Group (CBRE) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
CBRE (CBRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: T. Rowe Price, Best Buy, Celanese Corp, CBRE Group and Regeneron Pharma
by Zacks Equity Research
Zacks.com featured highlights include: T. Rowe Price, Best Buy, Celanese Corp, CBRE Group and Regeneron Pharma
5 High ROE Stocks to Buy as Markets Face Intense Volatility
by Supriyo Bose
T. Rowe Price Group (TROW), Best Buy (BBY), Celanese Corporation (CE), CBRE Group (CBRE), and Regeneron Pharmaceuticals (REGN) are some of the stocks with high ROE to buy in a volatile market.
Rexford (REXR) Enhances Portfolio, Buyouts Reach $1.3B in '21
by Zacks Equity Research
The acquisitions of industrial properties in the prime in-fill Southern California markets will aid Rexford (REXR) to benefit from the healthy market fundamentals.
Why This 1 Finance Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
5 Stocks With High ROE as Markets Await Fed Tapering Outlook
by Supriyo Bose
OneMain Holdings (OMF), KLA Corporation (KLAC), Bunge Limited (BG), CBRE Group, (CBRE) and Regeneron Pharmaceuticals (REGN) are some of the stocks with high ROE to buy as markets await Fed tapering clarity.
Rexford (REXR) Boosts Portfolio, Acquisitions Reach $1.03B in 2021
by Zacks Equity Research
The acquisition of industrial properties in the prime in-fill Southern California markets will aid Rexford (REXR) to benefit from the healthy market fundamentals.
CBRE (CBRE) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
CBRE (CBRE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Looking for a Growth Stock? 3 Reasons Why CBRE (CBRE) is a Solid Choice
by Zacks Equity Research
CBRE (CBRE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Add These 4 Stocks With Remarkable Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Herc Holdings (HRI), Dillard's (DDS), CBRE Group (CBRE) and The Interpublic Group of Companies (IPG) are strong enough to meet financial obligations.
Why CBRE Group (CBRE) is a Top Stock for the Long-Term
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
5 Stocks With High ROE as Markets Stumble on Tepid Jobs Report
by Supriyo Bose
T. Rowe Price Group (TROW), KLA Corporation (KLAC), Whirlpool Corporation (WHR), CBRE Group (CBRE) and Regeneron Pharmaceuticals (REGN) are some stocks with high ROE to buy as markets slip on weak jobs report.
Zacks Industry Outlook Highlights: CBRE Group, Jones Lang LaSalle and Realogy Holdings
by Zacks Equity Research
Zacks Industry Outlook Highlights: CBRE Group, Jones Lang LaSalle and Realogy Holdings
Retail Sales Down. Consumer Sentiment Down. What Gives?
by John Blank
What to expect from the upcoming holiday shopping season?
JLL or CBRE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
JLL vs. CBRE: Which Stock Is the Better Value Option?
3 Top Stocks From the Rebounding Real Estate Operations Industry
by Moumita C. Chattopadhyay
The Zacks Real Estate Operations industry stocks -- CBRE, JLL and RLGY -- are in focus thanks to acceleration of certain trends, outsourcing real estate needs, tech investments, vaccination and stimulus despite resurgence of COVID-19 cases with the Delta variant spread.
Looking for a Growth Stock? 3 Reasons Why CBRE (CBRE) is a Solid Choice
by Zacks Equity Research
CBRE (CBRE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Rexford's (REXR) Acquisitions Reach $779 Million in 2021 So Far
by Zacks Equity Research
Acquisition of industrial properties in prime in-fill Southern California markets will aid Rexford (REXR) to benefit from the healthy market fundamentals.
Add These 4 Stocks With Impressive Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Companies such as Dillard's (DDS), Herc Holdings (HRI), Echo Global (ECHO) and CBRE Group (CBRE) are sound enough to meet financial obligations.
Zacks.com featured highlights include: T. Rowe Price, KLA Corp, Whirlpool, CBRE Group and Regeneron Pharmaceuticals
by Zacks Equity Research
Zacks.com featured highlights include: T. Rowe Price, KLA Corp, Whirlpool, CBRE Group and Regeneron Pharmaceuticals
5 Stocks With High ROE to Buy Amid Fresh COVID-19 Fears
by Supriyo Bose
T. Rowe Price Group (TROW), KLA Corporation (KLAC), Whirlpool (WHR), CBRE Group (CBRE) and Regeneron Pharmaceuticals (REGN) are some of the stocks with high ROE to buy as coronavirus resurgence fear soars.
Zacks Market Edge Highlights: CBRE Group, Herman Miller, SPY, VOO and QQQM
by Zacks Equity Research
Zacks Market Edge Highlights: CBRE Group, Herman Miller, SPY, VOO and QQQM
How to Invest for the Future Economy
by Tracey Ryniec
We've had the pandemic stock winners and the recovery winners, but what happens next?